Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia · Delayed Price · Currency is AUD 0.2450
0.00 (0.00%)
Sep 18, 2026, 4:10 PM AEST
ASX:PAR Market Cap
ASX:PAR has a market cap or net worth of 146.8 million as of October 21, 2026. It is the 25,012th most valuable company in the world and the 527th biggest in Australia. Its market cap has increased by 27.32% in one year.
Market Cap
146.80M
Enterprise Value
138.87M
Revenue
n/a
Global Rank
Country Rank
#527 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 19, 2015, ASX:PAR's market cap has increased from 32.40M to 146.80M, an increase of 353.03%. That is a compound annual growth rate of 14.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 146.80M | 0.76% |
| Dec 31, 2025 | 145.70M | -0.23% |
| Dec 31, 2024 | 146.04M | -2.24% |
| Dec 29, 2023 | 149.39M | -62.33% |
| Dec 30, 2022 | 396.54M | -8.38% |
| Dec 31, 2021 | 432.81M | -25.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Racura Oncology | 305.87M |
| Tetratherix | 286.51M |
| Starpharma Holdings | 230.27M |
| BLS Pharmaceuticals | 213.03M |
| Actinogen Medical | 184.70M |
| Orthocell | 163.44M |
| Dimerix | 126.08M |
| Nyrada | 116.37M |